Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pierre Fabre Medicament
With
Pierre Fabre Pharma GmbH
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Presence of at least one measurable lesion (RECIST criteria)
Patients with a Karnofsky Performance Status = or \> 80%
Adequate pulmonary function, bone marrow, hepatic and renal functions
You may not be if
Patients with NSCLC stage IV, with NSCLC stages I, II, IIIA (except N2), with NSCLC stage IIIB with tumour extent or pleural effusion
Symptomatic neuropathy \> Grade 1
Hearing impairment = or \> Grade 2
Concomitant/uncontrolled medical disorder
Pregnant women
Clareo Health | Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer
